Marika J. Karkkainen

Author

Also Known As

Engelhard, M, M Karkkainen, M. Karkkainen, MARIKA J. KARKKAINEN, Marika J Karkkainen, Marika J. Karkkainen, Marika Karkkainen, Marika Kärkkäinen

Publications

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Ludwig Cancer Research University of Eastern Finland University of Pittsburgh

About

Marika J. Karkkainen is an author at University of Helsinki specializing in medicine, angiogenesis, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	6.8K
2	Health Sciences	1	1	745
3	Natural Sciences	1	1	75
4	Public Health	1	1	116
5	Social Sciences	1	1	177

Marika J. Karkkainen

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Marika J. Karkkainen, Paula Haiko, Kirsi Sainio, Nature Immunology Embryonic VeinsDevelopmental BiologyAngiogenesisFirst Lymphatic VesselsVascular Malformation	2003	1.4K
Regulation of angiogenesis via vascular endothelial growth factor receptors. Tanja Veikkola, Marika J. Karkkainen, Lena Claesson‐Welsh, PubMed Endothelial Cell PathobiologyCancer ResearchRadiation OncologyAngiogenesisSolid Tumors	2000	745
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Terhi Kärpänen, Mikala Egeblad, Marika J. Karkkainen, Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) ImmunologyPathologyTumor LymphangiogenesisTumor BiologyTumor Angiogenesis	2001	653
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema Marika J. Karkkainen, Robert E. Ferrell, Elizabeth Lawrence, Nature Genetics Lymphoid NeoplasiaMissense MutationsAutoimmune DiseaseImmunologyPathology	2000	650
Abnormal lymphatic vessel development in neuropilin 2 mutant mice Yuan Li, Delphine Moyon, Luc Pardanaud, Development Developmental BiologySignal TransductionAngiogenesisMedicineAutophagy	2002	618
A model for gene therapy of human hereditary lymphedema Marika J. Karkkainen, Anne Saaristo, Lotta Jussila, Proceedings of the National Academy of Sciences Human GrowthImmunologyPathologyBiological TherapyDermatology	2001	604
Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase Alexandre Irrthum, Marika J. Karkkainen, Koenraad Devriendt, The American Journal of Human Genetics Developmental BiologyGenetic DisorderImmunologyPathologyFibroblast Growth Factor	2000	433
Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites Johan Dixelius, Taija Mäkinen, Maria Wirzenius, Journal of Biological Chemistry ImmunologyTumor BiologyAngiogenesisSignaling PathwayReceptor Tyrosine Kinase	2003	278
Therapeutic lymphangiogenesis with human recombinant VEGF‐C Andrzej Szuba, Mihaela Skobe, Marika J. Karkkainen, The FASEB Journal AngiogenesisVegfr-3 ReceptorImmunologyLymphatic SystemTherapeutic Lymphangiogenesis	2002	255
Vascular Endothelial Growth Factor-C Accelerates Diabetic Wound Healing Anne Saaristo, Tuomas Tammela, Anniina Färkkilä, American Journal Of Pathology DiabetesWound CareVascular BiologyWound HealingBiomedical Engineering	2006	236

Page 1